Live feed07:30:00·7mPRReleasevia QuantisnowRadiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain MetastasesByQuantisnow·Wall Street's wire, on your screen.RADX· Radiopharm Theranostics LimitedHealth Care
